These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8103312)

  • 1. IMP dehydrogenase inhibitors as immunomodulators.
    Mitchell BS; Dayton JS; Turka LA; Thompson CB
    Ann N Y Acad Sci; 1993 Jun; 685():217-24. PubMed ID: 8103312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
    Dayton JS; Turka LA; Thompson CB; Mitchell BS
    Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.
    Turka LA; Dayton J; Sinclair G; Thompson CB; Mitchell BS
    J Clin Invest; 1991 Mar; 87(3):940-8. PubMed ID: 1999502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanine ribonucleotide depletion inhibits T cell activation.
    Dayton JS; Turka LA; Thompson CB; Mitchell BS
    Adv Exp Med Biol; 1991; 309B():293-6. PubMed ID: 1781385
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
    Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
    J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory mechanism of mizoribine on the antibody production of mouse B cells stimulated with lipopolysaccharide.
    Kamada H; Itoh H; Shibata H; Koshio T; Hayashi A; Nakagami K
    Jpn J Pharmacol; 1997 Aug; 74(4):323-30. PubMed ID: 9307328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
    Catapano CV; Dayton JS; Mitchell BS; Fernandes DJ
    Mol Pharmacol; 1995 May; 47(5):948-55. PubMed ID: 7746281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of mycophenolate mofetil.
    Ransom JT
    Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
    Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
    Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
    Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VX-497: a novel, selective IMPDH inhibitor and immunosuppressive agent.
    Jain J; Almquist SJ; Shlyakhter D; Harding MW
    J Pharm Sci; 2001 May; 90(5):625-37. PubMed ID: 11288107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of expression of cyclin A in human B cells by an immunosuppressant mizoribine.
    Hirohata S; Yanagida T
    J Immunol; 1995 Dec; 155(11):5175-83. PubMed ID: 7594527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
    Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.
    Nelson JA; Rose LM; Bennett LL
    Cancer Res; 1976 Apr; 36(4):1375-8. PubMed ID: 130972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GTP concentrations are elevated in erythrocytes of renal transplant recipients when conventional immunosuppression is replaced by the inosine monophosphate dehydrogenase inhibitor mycophenolic acid mofetil (MMF).
    Goldsmith DJ; Carrey EA; Edbury SM; Marinaki AM; Simmonds HA
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1407-9. PubMed ID: 15571268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
    Balzarini J; De Clercq E
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):785-90. PubMed ID: 1359876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.